Selected article for: "cc international license and low shedding"

Author: Dennis L Chao; Assaf P Oron; Devabhaktuni Srikrishna; Michael Famulare
Title: Modeling layered non-pharmaceutical interventions against SARS-CoV-2 in the United States with Corvid
  • Document date: 2020_4_11
  • ID: 3oovwwem_36
    Snippet: For the incubation period distribution (duration from infection to showing symptoms), we used the log-normal fit from [24] who used data from Shenzhen. They found parameters of log(mean)=1.621 and log(sd)=0.418 (Figure 8 ). There are reports that viral detection peaks a few days after symptoms. [25] found pharyngeal shedding to peak 4 days after symptoms using throat swabs. Therefore, we used the incubation period distribution and added 4 to the .....
    Document: For the incubation period distribution (duration from infection to showing symptoms), we used the log-normal fit from [24] who used data from Shenzhen. They found parameters of log(mean)=1.621 and log(sd)=0.418 (Figure 8 ). There are reports that viral detection peaks a few days after symptoms. [25] found pharyngeal shedding to peak 4 days after symptoms using throat swabs. Therefore, we used the incubation period distribution and added 4 to the mean (the log(mean) of the distribution is log(exp(1.621)+4)). That makes shedding peak 4 days after the median incubation period (Figure 8 ). It might make more sense for shedding to peak right after symptoms appear in an individual instead of independent of symptom onset. We assume that shedding lasts for 21 days, though the level of shedding is low by the end of the infectious period. We make asymptomatic individuals half as infectious as symptomatic. So if a person never becomes symptomatic, infectiousness is simply half that of a symptomatic individual over time. If a person becomes . CC-BY 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

    Search related documents:
    Co phrase search for related documents
    • asymptomatic individual and incubation period: 1, 2, 3
    • asymptomatic individual and infectious period: 1, 2
    • asymptomatic individual and international license: 1, 2
    • asymptomatic individual and symptom onset: 1, 2, 3
    • cc international license and day peak: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • cc international license and incubation period: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cc international license and incubation period distribution: 1, 2, 3, 4, 5, 6, 7
    • cc international license and infectious period: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cc international license and international license: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cc international license and median incubation period: 1, 2, 3, 4, 5
    • cc international license and person symptomatic: 1
    • cc international license and shedding level: 1, 2
    • cc international license and symptom onset: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • day peak and infectious period: 1, 2, 3
    • day peak and infectious period end: 1
    • day peak and international license: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • day peak and median incubation period: 1
    • day peak and pharyngeal shedding: 1
    • day peak and symptom onset: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18